Werner RA, Weich A, Kircher M, Solnes LB, Javadi MS, Higuchi T, et al. The theranostic promise for neuroendocrine tumors in the late 2010s - where do we stand, where do we go? Theranostics. 2018;8:6088–100. https://doi.org/10.7150/thno.30357.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, et al. Feasibility, biodistribution, and preliminary dosimetry in peptide-targeted radionuclide therapy of diverse adenocarcinomas using 177Lu-FAP-2286: first-in-humans results. J Nucl Med. 2022;63:415–23. https://doi.org/10.2967/jnumed.120.259192.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, et al. Lutetium-177–PSMA-617 for metastatic castration-resistant prostate Cancer. N Engl J Med. 2021. https://doi.org/10.1056/NEJMoa2107322.

Article  PubMed  PubMed Central  Google Scholar 

Stokke C, Gabina PM, Solny P, Cicone F, Sandstrom M, Gleisner KS, et al. Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force. EJNMMI Phys. 2017;4:27. https://doi.org/10.1186/s40658-017-0194-3.

Article  PubMed  PubMed Central  Google Scholar 

Erdi AK, Erdi YE, Yorke ED, Wessels BW. Treatment planning for radio-immunotherapy. Phys Med Biol. 1996;41:2009–26. https://doi.org/10.1088/0031-9155/41/10/011.

Article  CAS  PubMed  Google Scholar 

Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, et al. Potential impact of (68)Ga-PSMA-11 PET/CT on the planning of definitive Radiation therapy for prostate Cancer. J Nucl Med. 2018;59:1714–21. https://doi.org/10.2967/jnumed.118.209387.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baum RP, Kulkarni HR. THERANOSTICS: from molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy-the bad Berka experience. Theranostics. 2012;2:437–. https://doi.org/10.7150/thno.3645.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB, et al. MIRD pamphlet 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med. 2012;53:1310–25. https://doi.org/10.2967/jnumed.111.100123.

Article  CAS  PubMed  Google Scholar 

Zhuang X, Lu C. PBPK modeling and simulation in drug research and development. Acta Pharm Sinica B. 2016;6:430–40. https://doi.org/10.1016/j.apsb.2016.04.004.

Article  Google Scholar 

Kletting P, Thieme A, Eberhardt N, Rinscheid A, D’Alessandria C, Allmann J, et al. Modeling and predicting tumor response in radioligand therapy. J Nucl Med. 2019;60:65–70. https://doi.org/10.2967/jnumed.118.210377.

Article  CAS  PubMed  Google Scholar 

Xue S, Gafita A, Dong C, Zhao Y, Tetteh G, Menze BH, et al. Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy. Eur J Nucl Med Mol Imaging. 2022;49:4064–72. https://doi.org/10.1007/s00259-022-05883-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sgouros G, Bodei L, McDevitt MR, Nedrow JR. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discovery. 2020;19:589–608. doi:s41573-020-0073-9.

Article  CAS  PubMed  Google Scholar 

Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, et al. MIRD pamphlet 17: the dosimetry of nonuniform activity distributions—radionuclide S values at the voxel level. J Nucl Med. 1999;40:S11–36.

Google Scholar 

Ljungberg M, Gleisner KS. 3-D image-based dosimetry in radionuclide therapy. IEEE Trans Radiation Plasma Med Sci. 2018;2:527–40. https://doi.org/10.1109/TRPMS.2018.2860563.

Article  Google Scholar 

Zhou SK, Greenspan H, Davatzikos C, Duncan JS, Van Ginneken B, Madabhushi A et al. A review of deep learning in medical imaging: Imaging traits, technology trends, case studies with progress highlights, and future promises. Proceedings of the IEEE. 2021;109:820 – 38. https://doi.org/10.1109/JPROC.2021.3054390.

Halty A, Badel J-N, Kochebina O, Sarrut D. Image-based SPECT calibration based on the evaluation of the fraction of activity in the field of View. EJNMMI Phys. 2018;5:1–15. https://doi.org/10.1186/s40658-018-0209-8.

Article  Google Scholar 

Okamoto S, Thieme A, Allmann J, D’Alessandria C, Maurer T, Retz M, et al. Radiation dosimetry for 177Lu-PSMA I&T in metastatic castration-resistant prostate cancer: absorbed dose in normal organs and tumor lesions. J Nucl Med. 2017;58:445–50. https://doi.org/10.2967/jnumed.116.178483.

Article  CAS  PubMed  Google Scholar 

Mayerhoefer ME, Materka A, Langs G, Häggström I, Szczypiński P, Gibbs P, et al. Introduction to radiomics. J Nucl Med. 2020;61:488–95. https://doi.org/10.2967/jnumed.118.222893.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan H, Zhang G, Sun T, Ren J, Zhang Q, Xiang Z, et al. Kinetic modeling and parametric imaging of 18F-PSMA‐11: an evaluation based on total‐body dynamic positron emission tomography scans. Med Phys. 2024;51:156–66.

Article  CAS  PubMed  Google Scholar 

Chauvin M, Borys D, Botta F, Bzowski P, Dabin J, Denis-Bacelar AM, et al. OpenDose: open-Access Resource for Nuclear Medicine Dosimetry. J Nucl Med. 2020;61:1514–9. https://doi.org/10.2967/jnumed.119.240366.

Article  PubMed  PubMed Central  Google Scholar 

Menzel HG, Clement C, DeLuca P. ICRP publication 110. Realistic reference phantoms: an ICRP/ICRU joint effort. A report of adult reference computational phantoms. Ann ICRP. 2009;39:1–164. https://doi.org/10.1016/j.icrp.2009.09.001.

Article  PubMed  Google Scholar 

Goodfellow I, Pouget-Abadie J, Mirza M, Xu B, Warde-Farley D, Ozair S et al. Generative adversarial nets. Advances in neural information processing systems; 2014. p. 2672–80.

Pouliot F, Beauregard JM, Saad F, Trudel D, Richard PO, Turcotte É et al. The Triple-Tracer strategy against metastatic PrOstate cancer (3TMPO) study protocol. BJU Int. 2021.

Drzymala R, Mohan R, Brewster L, Chu J, Goitein M, Harms W, et al. Dose-volume histograms. Int J Radiation Oncology* Biology* Phys. 1991;21:71–8. https://doi.org/10.1016/0360-3016(91)90168-4.

Article  CAS  Google Scholar 

Tol JP, Dahele M, Delaney AR, Slotman BJ, Verbakel WF. Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans? Radiat Oncol. 2015;10:1–14. https://doi.org/10.1186/s13014-015-0542-1.

Article  Google Scholar 

Appenzoller LM, Michalski JM, Thorstad WL, Mutic S, Moore KL. Predicting dose-volume histograms for organs‐at‐risk in IMRT planning. Med Phys. 2012;39:7446–61. https://doi.org/10.1118/1.4761864.

Article  PubMed  Google Scholar 

Wasserthal J, Breit H-C, Meyer MT, Pradella M, Hinck D, Sauter AW et al. Totalsegmentator: Robust segmentation of 104 anatomic structures in ct images. Radiology: Artificial Intelligence. 2023;5.

Rathke H, Holland-Letz T, Mier W, Flechsig P, Mavriopoulou E, Röhrich M, et al. Response prediction of 177Lu-PSMA-617 radioligand therapy using prostate-specific antigen, chromogranin A, and lactate dehydrogenase. J Nucl Med. 2020;61:689–95. https://doi.org/10.2967/jnumed.119.231431.

Article  CAS  PubMed  Google Scholar 

Karimzadeh A, Heck M, Tauber R, Knorr K, Haller B, D’Alessandria C, et al. 177Lu-PSMA-I&T for treatment of metastatic castration-resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers. J Nucl Med. 2023;64:402–9. https://doi.org/10.2967/jnumed.122.264402.

Article  CAS  PubMed  Google Scholar 

Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature. J Nucl Med. 2009;50:477–84. https://doi.org/10.2967/jnumed.108.056036.

Article  CAS  PubMed  Google Scholar 

Ma C, Pawlicki T, Jiang S, Li J, Deng J, Mok E, et al. Monte Carlo verification of IMRT dose distributions from a commercial treatment planning optimization system. Phys Med Biol. 2000;45:2483. https://doi.org/10.1088/0031-9155/45/9/303.

Article  CAS  PubMed  Google Scholar 

Kolbert KS, Sgouros G, Scott AM, Bronstein JE, Malane RA, Zhang J, et al. Implementation and evaluation of patient-specific three-dimensional internal dosimetry. J Nucl Med. 1997;38:301–7.

CAS  PubMed  Google Scholar 

Furhang EE, Chui CS, Sgouros G. A Monte Carlo approach to patient-specific dosimetry. Med Phys. 1996;23:1523–9. https://doi.org/10.1118/1.597882.

Article  CAS  PubMed  Google Scholar 

Sohlberg A, Watabe H, Iida H. Acceleration of Monte Carlo-based scatter compensation for cardiac SPECT. Phys Med Biol. 2008;53:N277. https://doi.org/10.1088/0031-9155/53/14/N02.

Article  CAS  PubMed  Google Scholar 

Burrell S, MacDonald A. Artifacts and pitfalls in myocardial perfusion imaging. J Nucl Med Technol. 2006;34:193–211.

PubMed  Google Scholar 

Zhang A, Li J, Qiu H, Wang W, Guo Y. Comparison of rigid and deformable registration through the respiratory phases of four-dimensional computed tomography image data sets for radiotherapy after breast-conserving surgery. Medicine. 2017;96. https://doi.org/10.1097/MD.0000000000009143.

Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, et al. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut. 2015. https://doi.org/10.1136/gutjnl-2014-308008.

Article  PubMed  Google Scholar